Correction: Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.
- DOI
- 10.1038/s41401-026-01798-6
- Published
- 2026 Sep
- Container
- Acta pharmacologica Sinica
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41401-026-01798-6,
title = {Correction: Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.},
author = {Tian M and Chen XS and Li LY and Wu HZ and Zeng D and Wang XL and Zhang Y and Xiao SS and Cheng Y},
year = {2026},
journal = {Acta pharmacologica Sinica},
doi = {10.1038/s41401-026-01798-6},
url = {https://doi.org/10.1038/s41401-026-01798-6}
}RIS
TY - JOUR TI - Correction: Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis. AU - Tian M AU - Chen XS AU - Li LY AU - Wu HZ AU - Zeng D AU - Wang XL AU - Zhang Y AU - Xiao SS AU - Cheng Y PY - 2026 JO - Acta pharmacologica Sinica DO - 10.1038/s41401-026-01798-6 UR - https://doi.org/10.1038/s41401-026-01798-6 ER -
APA
M, T., XS, C., LY, L., HZ, W., D, Z., XL, W., Y, Z., SS, X., & Y, C. (2026). Correction: Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.. Acta pharmacologica Sinica. https://doi.org/10.1038/s41401-026-01798-6
Source records
- pubmed · retrieved 2026-09-26T03:52:23.504Z